COVID-19 infection and autoimmunity not linked to developing type 1 diabetes in children: JAMA
Researchers from Colorado and Bavaria, Germany have found in a new study published in the JAMA conducted on over 50,000 kids that there was no link between COVID-19 infection and autoimmunity linked to developing type 1 diabetes.
An increased incidence of clinical diabetes has been reported in children with previous COVID-19.1,2 It is plausible that the virus may trigger an autoimmune response to the islets or hasten metabolic decompensation in persons with already established islets autoimmunity. We tested the hypothesis that previous SARS-CoV-2 infection was associated with autoimmunity, which predicts future type 1 diabetes.
In 2020 and 2021, a cross-sectional screening for islet autoantibodies and SARS-CoV-2 antibodies was offered to children and adolescents aged 1 to 18 years participating in the Autoimmunity Screening for Kids (ASK)3 in Colorado, US, and to children aged 1 to 10.9 years enrolled in the Fr1da study in Bavaria, Germany.
The results of the study are:
- Prior SARS-CoV-2 infections were identified in 1524 (32.3%) of 4717 Colorado youths and in 2862 (6.1%) of 47 253 Bavarian children
- Multiple islet autoantibodies were detected in 21 Colorado youths (0.45%) and in 141 Bavarian children (0.30%). In addition, 26 (0.55%) and 54 (0.11%) Colorado and Bavarian youths, respectively, were positive for a single high-affinity islet autoantibody.
- The prevalence of multiple or single high-affinity islet autoantibodies did not significantly differ between youths with vs without previous SARS-CoV-2 infection in Colorado or Bavaria
- Previous SARS-CoV-2 infection was not significantly associated with the presence of multiple islet autoantibodies or a single high-affinity islet autoantibody controlling for confounders.
Thus, the researchers concluded that there was no significant interaction between the study site and the association with SARS-CoV-2 infection, sex, age, or family history of type 1 diabetes
Reference:
Rewers M, Bonifacio E, Ewald D, et al. SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany. JAMA. Published online August 05, 2022. doi:10.1001/jama.2022.14092
Keywords:
type 1 diabetes, COVID-19, infection, autoimmunity, Colorado, Bavaria, Germany, Adolescent Medicine, Marian Rewers, Ezio Bonifacio, Dominik Ewald, Cristy Geno Rasmussen, Xiaofan Jia, Laura Pyle, Anette-Gabriele Ziegler,JAMA
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.